Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

JAK inhibitors are effective treatments for alopecia areata.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Tofacitinib effectively treats Alopecia Areata.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Dupilumab helps children with alopecia areata regrow hair safely.

Ritlecitinib can help about 14,000 people with severe hair loss.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.